Mar 14, 2023 / 02:15PM GMT
Matthew Stephan Miksic - Barclays Bank PLC, Research Division - Research Analyst
Here in U.S. for Barclays. I'm very, very pleased to have with us today, J&J. From J&J, we've got Aldo Denti, Company Group Chairman of DePuy Synthes; and Peter Menziuso, Company Group Chairman of Johnson & Johnson Vision. So thanks so much, guys, for joining us today.
Aldo Denti - - Company Group Chairman of DePuy Synthes
Thank you for having us.
Questions and Answers:
Matthew Stephan Miksic - Barclays Bank PLC, Research Division - Research AnalystSo I'll try to keep you both kind of engaged and busy here. We'll hop back and forth between Vision and Ortho. Maybe starting with Orthopaedics, Aldo, so I think one of the developments over the past year has been that, let's just say, after a number of years of growing kind of at a more muted growth rate, Orthopaedics, in particular, and some of your other musculoskeletal businesses have really started to kind of lift off.
So maybe can you talk about some of the